1. Rinaldi MG. Phaeohyphomycosis. Dermatol Clin. 1996. 14:147–153.
Article
2. Madan V, Bisset D, Harris P, Howard S, Beck MH. Phaeohyphomycosis caused by Exophiala salmonis. Br J Dermatol. 2006. 155:1082–1084.
Article
3. Otis EJ, Wolke RE, Blazer VS. Infection of Exophiala salmonis in Atlantic salmon (Salmo salar L.). J Wildl Dis. 1985. 21:61–64.
Article
4. Ajello L, Georg LK, Steigbigel RT, Wang CJ. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia. 1974. 66:490–498.
Article
5. Suh MK, Kwon SW, Kim TH, Sun YW, Lim JW, Ha GY, et al. A case of subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei. Korean J Dermatol. 2005. 43:124–127.
6. Koga T, Matsuda T, Matsumoto T, Furue M. Therapeutic approaches to subcutaneous mycoses. Am J Clin Dermatol. 2003. 4:537–543.
Article
7. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis. 2009. 48:1033–1041.
Article
8. Rossetto AL, Dellatorre G, Pérsio RA, Romeiro JC, Cruz RC. Subcutaneous phaeohyphomycosis on the scrotum caused by Exophiala jeanselmei: case report. An Bras Dermatol. 2010. 85:517–520.
9. Ronan SG, Uzoaru I, Nadimpalli V, Guitart J, Manaligod JR. Primary cutaneous phaeohyphomycosis: report of seven cases. J Cutan Pathol. 1993. 20:223–228.
Article
10. Suh MK. Phaeohyphomycosis in Korea. Nihon Ishinkin Gakkai Zasshi. 2005. 46:67–70.
Article
11. Choi J, Lee Y, Chung HS, Koo JS, Yong D, Kim YS, et al. Subcutaneous phaeohyphomycosis caused by Phaeoacremonium species in a kidney transplant patient: the first case in Korea. Korean J Lab Med. 2011. 31:201–204.
12. Jeong ES, Shin JH, Shin MG, Suh SP, Ryang DW. Fungemia due to Exophiala dermatitidis. Korean J Clin Microbiol. 2010. 13:135–139.
13. Kim DS, Yoon YM, Kim SW. Phaeohyphomycosis due to Exophiala dermatitidis successfully treated with Itraconazole. Korean J Med Mycol. 1999. 4:79–83.
14. Chang CL, Kim DS, Park DJ, Kim HJ, Lee CH, Shin JH. Acute cerebral phaeohyphomycosis due to Wangiella dermatitidis accompanied by cerebrospinal fluid eosinophilia. J Clin Microbiol. 2000. 38:1965–1966.
15. Clinical and Laboratory Standards Institute. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing. 1st ed. approved guideline, MM18-A. 2008. Wayne, PA: Clinical and Laboratory Standards Institute.
16. Jang JH, Lee JH, Ki CS, Lee NY. Identification of clinical mold isolates by sequence analysis of the internal transcribed spacer region, ribosomal large-subunit D1/D2, and beta-tubulin. Ann Lab Med. 2012. 32:126–132.
17. Nomura M, Maeda M, Seishima M. Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei in collagen disease patient. J Dermatol. 2010. 37:1046–1050.
Article
18. Aoyama Y, Nomura M, Yamanaka S, Ogawa Y, Kitajima Y. Subcutaneous phaeohyphomycosis caused by Exophiala xenobiotica in a non-Hodgkin lymphoma patient. Med Mycol. 2009. 47:95–99.
19. Sharkey PK, Graybill JR, Rinaldi MG, Stevens DA, Tucker RM, Peterie JD, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol. 1990. 23:577–586.
Article